167 related articles for article (PubMed ID: 28212563)
1. Progression of motor deficits in glioma-bearing mice: impact of CNF1 therapy at symptomatic stages.
Vannini E; Maltese F; Olimpico F; Fabbri A; Costa M; Caleo M; Baroncelli L
Oncotarget; 2017 Apr; 8(14):23539-23550. PubMed ID: 28212563
[TBL] [Abstract][Full Text] [Related]
2. The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model.
Vannini E; Panighini A; Cerri C; Fabbri A; Lisi S; Pracucci E; Benedetto N; Vannozzi R; Fiorentini C; Caleo M; Costa M
BMC Cancer; 2014 Jun; 14():449. PubMed ID: 24939046
[TBL] [Abstract][Full Text] [Related]
3. CTX-CNF1 Recombinant Protein Selectively Targets Glioma Cells In Vivo.
Vannini E; Mori E; Tantillo E; Schmidt G; Caleo M; Costa M
Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33800135
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiology of glioma: a Rho GTPase-activating protein reduces tumor growth and spares neuron structure and function.
Vannini E; Olimpico F; Middei S; Ammassari-Teule M; de Graaf EL; McDonnell L; Schmidt G; Fabbri A; Fiorentini C; Baroncelli L; Costa M; Caleo M
Neuro Oncol; 2016 Dec; 18(12):1634-1643. PubMed ID: 27298309
[TBL] [Abstract][Full Text] [Related]
5. Cnf1 Variants Endowed with the Ability to Cross the Blood-Brain Barrier: A New Potential Therapeutic Strategy for Glioblastoma.
Colarusso A; Maroccia Z; Parrilli E; Germinario EAP; Fortuna A; Loizzo S; Ricceri L; Tutino ML; Fiorentini C; Fabbri A
Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32375387
[TBL] [Abstract][Full Text] [Related]
6. Modulation of RhoGTPases improves the behavioral phenotype and reverses astrocytic deficits in a mouse model of Rett syndrome.
De Filippis B; Fabbri A; Simone D; Canese R; Ricceri L; Malchiodi-Albedi F; Laviola G; Fiorentini C
Neuropsychopharmacology; 2012 Apr; 37(5):1152-63. PubMed ID: 22157810
[TBL] [Abstract][Full Text] [Related]
7. CNF1 Enhances Brain Energy Content and Counteracts Spontaneous Epileptiform Phenomena in Aged DBA/2J Mice.
Travaglione S; Ballan G; Fortuna A; Ferri A; Guidotti M; Campana G; Fiorentini C; Loizzo S
PLoS One; 2015; 10(10):e0140495. PubMed ID: 26457896
[TBL] [Abstract][Full Text] [Related]
8. Treatment with the Bacterial Toxin CNF1 Selectively Rescues Cognitive and Brain Mitochondrial Deficits in a Female Mouse Model of Rett Syndrome Carrying a MeCP2-Null Mutation.
Urbinati C; Cosentino L; Germinario EAP; Valenti D; Vigli D; Ricceri L; Laviola G; Fiorentini C; Vacca RA; Fabbri A; De Filippis B
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201747
[TBL] [Abstract][Full Text] [Related]
9. Bacterial Toxins and Targeted Brain Therapy: New Insights from Cytotoxic Necrotizing Factor 1 (CNF1).
Tantillo E; Colistra A; Vannini E; Cerri C; Pancrazi L; Baroncelli L; Costa M; Caleo M
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857515
[TBL] [Abstract][Full Text] [Related]
10. The Rac GTPase-activating bacterial protein toxin CNF1 induces analgesia up-regulating mu-opioid receptors.
Pavone F; Luvisetto S; Marinelli S; Straface E; Fabbri A; Falzano L; Fiorentini C; Malorni W
Pain; 2009 Sep; 145(1-2):219-29. PubMed ID: 19608345
[TBL] [Abstract][Full Text] [Related]
11. Temozolomide combined with PD-1 Antibody therapy for mouse orthotopic glioma model.
Dai B; Qi N; Li J; Zhang G
Biochem Biophys Res Commun; 2018 Jul; 501(4):871-876. PubMed ID: 29758196
[TBL] [Abstract][Full Text] [Related]
12. A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model.
Towner RA; Ihnat M; Saunders D; Bastian A; Smith N; Pavana RK; Gangjee A
BMC Cancer; 2015 Jul; 15():522. PubMed ID: 26177924
[TBL] [Abstract][Full Text] [Related]
13. A therapeutic cancer vaccine against GL261 murine glioma.
Kindy MS; Yu J; Zhu H; Smith MT; Gattoni-Celli S
J Transl Med; 2016 Jan; 14():1. PubMed ID: 26727970
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis.
Davis JM; Carvalho HM; Rasmussen SB; O'Brien AD
Infect Immun; 2006 Aug; 74(8):4401-8. PubMed ID: 16861625
[TBL] [Abstract][Full Text] [Related]
15. The Rho GTPase activating CNF1 improves associative working memory for object-in-place.
De Viti S; Martino A; Musilli M; Fiorentini C; Diana G
Behav Brain Res; 2010 Sep; 212(1):78-83. PubMed ID: 20362628
[TBL] [Abstract][Full Text] [Related]
16. An Adult Drosophila Glioma Model for Studying Pathometabolic Pathways of Gliomagenesis.
Chi KC; Tsai WC; Wu CL; Lin TY; Hueng DY
Mol Neurobiol; 2019 Jun; 56(6):4589-4599. PubMed ID: 30357574
[TBL] [Abstract][Full Text] [Related]
17. The bacterial protein CNF1 as a new strategy against Plasmodium falciparum cytoadherence.
Messina V; Loizzo S; Travaglione S; Bertuccini L; Condello M; Superti F; Guidotti M; Alano P; Silvestrini F; Fiorentini C
PLoS One; 2019; 14(3):e0213529. PubMed ID: 30845261
[TBL] [Abstract][Full Text] [Related]
18. ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models.
Ziegler J; Pody R; Coutinho de Souza P; Evans B; Saunders D; Smith N; Mallory S; Njoku C; Dong Y; Chen H; Dong J; Lerner M; Mian O; Tummala S; Battiste J; Fung KM; Wren JD; Towner RA
Neuro Oncol; 2017 Feb; 19(2):175-185. PubMed ID: 27416955
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy.
Baker GJ; Yadav VN; Motsch S; Koschmann C; Calinescu AA; Mineharu Y; Camelo-Piragua SI; Orringer D; Bannykh S; Nichols WS; deCarvalho AC; Mikkelsen T; Castro MG; Lowenstein PR
Neoplasia; 2014 Jul; 16(7):543-61. PubMed ID: 25117977
[TBL] [Abstract][Full Text] [Related]
20. CNF1 improves astrocytic ability to support neuronal growth and differentiation in vitro.
Malchiodi-Albedi F; Paradisi S; Di Nottia M; Simone D; Travaglione S; Falzano L; Guidotti M; Frank C; Cutarelli A; Fabbri A; Fiorentini C
PLoS One; 2012; 7(4):e34115. PubMed ID: 22523545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
